Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features.

Rothschild AJ, Williamson DJ, Tohen MF, Schatzberg A, Andersen SW, Van Campen LE, Sanger TM, Tollefson GD.

J Clin Psychopharmacol. 2004 Aug;24(4):365-73.

PMID:
15232326
2.

Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.

Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M.

J Clin Psychiatry. 2009 Oct;70(10):1424-31. doi: 10.4088/JCP.08m04772gre.

PMID:
19906346
3.

A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression.

Corya SA, Williamson D, Sanger TM, Briggs SD, Case M, Tollefson G.

Depress Anxiety. 2006;23(6):364-72.

PMID:
16710853
4.

Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance.

Shelton RC, Williamson DJ, Corya SA, Sanger TM, Van Campen LE, Case M, Briggs SD, Tollefson GD.

J Clin Psychiatry. 2005 Oct;66(10):1289-97.

PMID:
16259543
5.

A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder.

Thase ME, Corya SA, Osuntokun O, Case M, Henley DB, Sanger TM, Watson SB, Dubé S.

J Clin Psychiatry. 2007 Feb;68(2):224-36.

PMID:
17335320
6.
7.

An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses.

Matthews JD, Bottonari KA, Polania LM, Mischoulon D, Dording CM, Irvin R, Fava M.

J Clin Psychiatry. 2002 Dec;63(12):1164-70.

PMID:
12523877
8.

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.

Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW, Evans AR, Beymer K, Dube S, Tollefson GD, Breier A.

Arch Gen Psychiatry. 2003 Nov;60(11):1079-88. Erratum in: Arch Gen Psychiatry. 2004 Feb;61(2):176.

PMID:
14609883
10.

A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression.

Corya SA, Perlis RH, Keck PE Jr, Lin DY, Case MG, Williamson DJ, Tohen MF.

J Clin Psychiatry. 2006 May;67(5):798-806.

PMID:
16841630
11.

Fluoxetine and olanzapine combination therapy in treatment-resistant major depression: review of efficacy and safety data.

Bobo WV, Shelton RC.

Expert Opin Pharmacother. 2009 Sep;10(13):2145-59. doi: 10.1517/14656560903130609. Review.

PMID:
19640209
12.

Effect of comorbid anxiety on treatment response in bipolar depression.

Tohen M, Calabrese J, Vieta E, Bowden C, Gonzalez-Pinto A, Lin D, Xu W, Corya S.

J Affect Disord. 2007 Dec;104(1-3):137-46. Epub 2007 May 21.

PMID:
17512607
13.

Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression.

Keck PE Jr, Corya SA, Altshuler LL, Ketter TA, McElroy SL, Case M, Briggs SD, Tohen M.

J Clin Psychiatry. 2005 May;66(5):611-6.

PMID:
15889948
14.

Clinical relevance of depressive symptom improvement in bipolar I depressed patients.

Williamson D, Brown E, Perlis RH, Ahl J, Baker RW, Tohen M.

J Affect Disord. 2006 Jun;92(2-3):261-6. Epub 2006 Mar 24.

PMID:
16563521
15.

A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.

Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J, Murck H, Rosenbaum JF.

J Clin Psychopharmacol. 2005 Oct;25(5):441-7.

PMID:
16160619
16.
17.

Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease.

De Deyn PP, Carrasco MM, Deberdt W, Jeandel C, Hay DP, Feldman PD, Young CA, Lehman DL, Breier A.

Int J Geriatr Psychiatry. 2004 Feb;19(2):115-26.

PMID:
14758577
18.

Randomized, double-blind 6-month comparison of olanzapine and quetiapine in patients with schizophrenia or schizoaffective disorder with prominent negative symptoms and poor functioning.

Kinon BJ, Noordsy DL, Liu-Seifert H, Gulliver AH, Ascher-Svanum H, Kollack-Walker S.

J Clin Psychopharmacol. 2006 Oct;26(5):453-61. Erratum in: J Clin Psychopharmacol. 2009 Apr;29(2):169.

PMID:
16974184
19.

Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studies.

Tohen M, Case M, Trivedi MH, Thase ME, Burke SJ, Durell TM.

J Clin Psychiatry. 2010 Apr;71(4):451-62. doi: 10.4088/JCP.08m04984gre. Epub 2010 Feb 23.

PMID:
20361905
20.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
Items per page

Supplemental Content

Write to the Help Desk